Resources with keywords: zika virus
From FDA’s Release: Ixchiq is administered as a single dose by injection into the muscle. It contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.
Reference document on Chikungunya Virus
This chapter includes information on the agent, transmission, diagnosis, treatment, prevention, epidemiology
NIAID is developing multiple vaccine candidates to prevent Zika virus infection.
clinical evaluation, sexual transmission, infection control